Multiscan
Multiscan is a Czech Republic-based comprehensive oncology and radiology center operating seven locations as the designated KOC of the Pardubice Region, delivering clinical oncology, radiation therapy, diagnostics, and pharmacy services to insured and self-pay patients.
- Company typePrivate
- Founded2005
- HeadquartersPardubice, Czechia
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Multiscan does
Multiscan s.r.o. is a Czech Republic-based private healthcare provider operating as a comprehensive oncology and radiology center, designated as the Komplexní onkologické centrum (KOC) Pardubického kraje — the Comprehensive Oncology Center of the Pardubice Region. The company is a subsidiary of AKESO holding a.s., which is owned by Ing. Sotirios Zavalianis, and operates seven locations across Pardubice, Chrudim, Svitavy, Ústí nad Orlicí, Hořovice, and Prague. Its service portfolio spans clinical oncology, radiation oncology (including linear accelerators and brachytherapy), radiodiagnostics, palliative care, preventive medicine, genetic counseling, physiotherapy, and an in-house pharmacy division called Multiscan Pharma that supports clinical trial participation.
The company's revenue model is anchored in the Czech public healthcare reimbursement system, serving insured patients through regional referrals for complex oncology care, supplemented by self-pay preventive and screening services. Multiscan holds ISO 9001 certification from TÜV SÜD and was awarded the Czech Best Managed Companies 2026 Platinum Award by Deloitte, reflecting recognized quality management standards. The company has secured EU structural funding — including EU Next Generation support in 2025 and a prior EU OP Zaměstnanost grant in 2018 — and has committed to an 84 million CZK equipment modernization program to upgrade radiotherapy and diagnostic imaging technology.
Operationally, Multiscan runs a multi-modality, multi-site clinical platform with named clinical leadership in radiation oncology, clinical oncology, medical physics, and radiodiagnostics. The integration of pharmacy, palliative care, and genetic counseling under a single entity creates a vertically oriented oncology care pathway. Its strategic positioning as a regional KOC center creates regulatory protection from new entrants while its seven-site distribution creates patient access advantages within its catchment area.
Multiscan firmographics
Firmographics- Name
- Multiscan
- Legal name
- Multiscan s.r.o.
- Website
- https://multiscan.cz
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Multiscan is a Czech Republic-based comprehensive oncology and radiology center operating seven locations as the designated KOC of the Pardubice Region, delivering clinical oncology, radiation therapy, diagnostics, and pharmacy services to insured and self-pay patients.
- Ownership category
- akta.pro rank
Multiscan industry classification
Industry- Product category
- Oncology and Radiology Healthcare Services
- NAICS
- Offices of Physicians (62111), Diagnostic Imaging Centers (621512)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)
- akta.pro secondary industries
- Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC), Oncology & Cancer Specialty Hospitals (HLAFAHAC)
Keywords
Where Multiscan is headquartered
LocationHeadquarters
- HQ city
- Pardubice
- HQ country
- Czechia
- HQ region
- Europe
Offices7 records
Markets served
Multiscan business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Clinical Oncology Services: Provides outpatient clinical oncology consultations, chemotherapy administration, and ongoing cancer care management. Services are primarily covered through public health insurance in Czech Republic.
- Radiation Oncology: Radiotherapy treatments including linear accelerator treatments and brachytherapy, funded through health insurance and EU-supported equipment modernization.
- Radiodiagnostics: Diagnostic imaging services including MRI, CT, X-ray, and ultrasound, available both through public insurance and self-payer arrangements.
- Self-Payer Services: Private healthcare services for patients without public insurance coverage or seeking faster access to diagnostic and treatment services.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Multiscan product offering
Product offeringCore offering
Multiscan is a Comprehensive Oncology Center providing integrated cancer care through three main service lines: clinical oncology (chemotherapy administration and medical oncology consultations), radiation oncology (linear accelerator external beam radiotherapy, brachytherapy, and CT simulation), and radiodiagnostics (MRI, CT, X-ray, ultrasound, and lung screening). The center supplements these core services with palliative care, hereditary cancer syndrome counseling, preventive screening, oncology physiotherapy, and clinical trials support through its Multiscan Pharma unit, operating across the Pardubice Region and Hořovice.
Product overview
Multiscan is a comprehensive oncology and radiology center operating as part of the AKESO holding group. The organization provides an integrated healthcare portfolio consisting of Clinical Oncology Services (chemotherapy and medical oncology across multiple regional locations), Radiation Oncology (external beam radiotherapy, brachytherapy, linear accelerator treatments), and Radiodiagnostics (MRI, CT, X-ray, ultrasound, lung screening). Specialized services include palliative care, preventive medicine, hereditary cancer syndrome counseling, and oncology physiotherapy. The subsidiary Multiscan Pharma supports clinical trials and pharmaceutical services. Multiscan serves as part of the Comprehensive Oncology Center of the Pardubice Region (KOC PK).
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Oncology Services
- Radiation Oncology
- Radiodiagnostics
- Palliative Care
- Preventive Outpatient Clinic
- Hereditary Cancer Syndromes
- Oncology Physiotherapy
- Multiscan Pharma
- Lung Screening
- Linear Accelerator Treatment
- Brachytherapy
Companies that use Multiscan
Customer profileSegments3 records
Ideal customer profiles2 records
Multiscan technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Multiscan partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered minor and core.
- European Union / OP ZaměstnanostminorEU-funded employee education project (CZ.03.1.52/0.0/0.0/16_043/0004691) with maximum support of 729,132 CZK for staff training and professional development.
- AKESO HoldingcoreMultiscan is a subsidiary of AKESO Holding, a healthcare group operating multiple hospitals, rehabilitation facilities, and outpatient clinics across Czech Republic including Nemocnice Hořovice, Rehabilitační nemocnice Beroun, and various AKESO POLIKLINIKA locations. The holding provides corporate governance, shared services, and strategic direction.
- Komplexní onkologické centrum Pardubického kraje (KOC PK)coreMultiscan is an integral part of the Comprehensive Oncology Center of the Pardubice Region (KOC PK), a formal regional healthcare designation for specialized oncology services requiring multidisciplinary coordination and adherence to treatment standards.
- European Union / Nástroj pro oživení a odolnostcoreEU-funded project (CZ.31.8.0/0.0/0.0/23_072/0008223) supporting equipment modernization for advanced diagnostics and radiotherapy treatment through National Recovery Plan of Czech Republic.
Scale indicators3 records
Recent moves5 records
Expansion highlights5 records
Multiscan competitors and assessment
Company assessmentDirect peers
- General University Hospital Prague (VFN) — Onkologická klinika: Prague-based academic comprehensive cancer center providing full-scope medical, radiation, and surgical oncology. Comparable as a competing Czech KOC with multidisciplinary cancer care, clinical research, and complex case referral infrastructure.
- FN Brno — Masaryk University Hospital Oncology Center: Large university hospital providing comprehensive cancer care including chemotherapy, radiotherapy, and radiodiagnostics in Moravia. Comparable as another full-service Czech academic KOC competitor.
- University Hospital Ostrava — Comprehensive Oncology Center: Designated KOC for the Moravian-Silesian region offering chemotherapy, radiotherapy, and oncological diagnostics. Comparable as one of the regional KOCs in the Czech network competing with Multiscan for tertiary oncology referrals.
- University Hospital Olomouc — KOC PK region competitor: Czech university hospital functioning as a Comprehensive Oncology Center with radiation oncology and chemotherapy services. Comparable as a regional Czech KOC competing for insured oncology patients and physician talent.
- Proton Therapy Center Czech: Prague-based specialized radiotherapy center offering advanced particle therapy and conventional radiotherapy. Comparable as a Czech specialty cancer treatment provider competing for complex radiotherapy cases that Multiscan's linear accelerators also aim to capture.
- Masaryk Memorial Cancer Institute (MOÚ Brno): The largest Czech specialized oncology hospital and KOC, located in Brno. Directly comparable to Multiscan as a Comprehensive Oncology Center providing radiation oncology, medical oncology, and radiodiagnostics across multiple locations in the Czech Republic.
- University Hospital Hradec Králové — KOC: Czech university hospital with comprehensive oncology, radiotherapy, and imaging services serving the eastern Bohemian region. Comparable as a neighboring KOC competing for patient referrals in geographies adjacent to Multiscan's Pardubice catchment.
Regional players
- MEDESA — Czech radiotherapy provider chain: Czech private radiotherapy and oncology services operator with multiple regional sites. Comparable as a competing private radiotherapy operator in the Czech market targeting similar insured oncology patient volumes.
Broad incumbents
- Agel — Czech private healthcare network: Largest Czech private healthcare operator running hospitals, clinics, and specialty centers including oncology services. Comparable as a multi-site private healthcare competitor with broader geographic reach than Multiscan.
Others
- AKESO Holding hospitals (Nemocnice Hořovice, Beroun): Sister facilities under the same parent holding as Multiscan. Not direct competitors but adjacent providers within the AKESO network that share governance, capital allocation, and patient referral pathways with Multiscan.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Multiscan social profiles
Digital presenceMultiscan compliance and trust
Trust signalCompliance2 records
Multiscan financial estimates
Financial estimateRevenue estimate
Valuation estimate
Multiscan leadership team
Management profileNumber of profiles
Profiles14 records
Multiscan funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Multiscan M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Multiscan
What does Multiscan do?
Multiscan is a Comprehensive Oncology Center providing integrated cancer care through three main service lines: clinical oncology (chemotherapy administration and medical oncology consultations), radiation oncology (linear accelerator external beam radiotherapy, brachytherapy, and CT simulation), and radiodiagnostics (MRI, CT, X-ray, ultrasound, and lung screening). The center supplements these core services with palliative care, hereditary cancer syndrome counseling, preventive screening, oncology physiotherapy, and clinical trials support through its Multiscan Pharma unit, operating across the Pardubice Region and Hořovice.
Is Multiscan a public or private company?
Multiscan is a private company. It is classified as corporate owned and is currently operating.
When was Multiscan founded?
Multiscan was founded in 2005. It employs 51 to 100 people.
Where is Multiscan based?
Multiscan is headquartered in Pardubice, Czechia, in the Europe region.
How does Multiscan make money?
Four revenue lines are on record. Clinical Oncology Services are the primary driver. The others are radiation Oncology, radiodiagnostics and self-Payer Services.
Who are Multiscan's main competitors?
Direct peers on record are General University Hospital Prague (VFN) — Onkologická klinika, FN Brno — Masaryk University Hospital Oncology Center, University Hospital Ostrava — Comprehensive Oncology Center, University Hospital Olomouc — KOC PK region competitor, Proton Therapy Center Czech, Masaryk Memorial Cancer Institute (MOÚ Brno) and University Hospital Hradec Králové — KOC. MEDESA — Czech radiotherapy provider chain is listed as a regional player. Agel — Czech private healthcare network is listed as a broad incumbent. AKESO Holding hospitals (Nemocnice Hořovice, Beroun) is listed as an others.
Does Multiscan have an API?
No public API is recorded for Multiscan.
What industry is Multiscan in?
Multiscan's product category is Oncology and Radiology Healthcare Services. Its primary akta.pro industry code is HLAFABAI, Ambulatory Oncology Centers (Outpatient Chemo/Radiation), with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 62111 and its SIC code is 8011.